Advanced and Selected Solid Tumors Completed Phase 1 Trials for Binimetinib (DB11967)

IndicationStatusPhase
DBCOND0047995 (Advanced and Selected Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01449058A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid TumorsTreatment